Literature DB >> 12755599

BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.

Nathaniel C Gordon1, Borlan Pan, Sarah G Hymowitz, JianPing Yin, Robert F Kelley, Andrea G Cochran, Minhong Yan, Vishva M Dixit, Wayne J Fairbrother, Melissa A Starovasnik.   

Abstract

BAFF/BLyS, a member of the tumor necrosis family (TNF) superfamily of ligands, is a crucial survival factor for B cells. BAFF binds three receptors, TACI, BCMA, and BR3, with signaling through BR3 being essential for promoting B cell function. Typical TNF receptor (TNFR) family members bind their cognate ligands through interactions with two cysteine-rich domains (CRDs). However, the extracellular domain (ECD) of BR3 consists of only a partial CRD, with cysteine spacing distinct from other modules described previously. Herein, we report the solution structure of the BR3 ECD. A core region of only 19 residues adopts a stable structure in solution. The BR3 fold is analogous to the first half of a canonical TNFR CRD but is stabilized by an additional noncanonical disulfide bond. BAFF-binding determinants were identified by shotgun alanine-scanning mutagenesis of the BR3 ECD expressed on phage. Several of the key BAFF-binding residues are presented from a beta-turn that we have shown previously to be sufficient for ligand binding when transferred to a structured beta-hairpin scaffold [Kayagaki, N., Yan, M., Seshasayee, D., Wang, H., Lee, W., French, D. M., Grewal, I. S., Cochran, A. G., Gordon, N. C., Yin, J., Starovasnik, M. A, and Dixit, V. M. (2002) Immunity 10, 515-524]. Outside of the turn, mutagenesis identifies additional hydrophobic contacts that enhance the BAFF-BR3 interaction. The crystal structure of the minimal hairpin peptide, bhpBR3, in complex with BAFF reveals intimate packing of the six-residue BR3 turn into a cavity on the ligand surface. Thus, BR3 binds BAFF through a highly focused interaction site, unprecedented in the TNFR family.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12755599     DOI: 10.1021/bi034017g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Relationship between hot spot residues and ligand binding hot spots in protein-protein interfaces.

Authors:  Brandon S Zerbe; David R Hall; Sandor Vajda; Adrian Whitty; Dima Kozakov
Journal:  J Chem Inf Model       Date:  2012-07-24       Impact factor: 4.956

Review 2.  Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling.

Authors:  Francis Ka-Ming Chan
Journal:  Cytokine       Date:  2007-04-20       Impact factor: 3.861

Review 3.  The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity.

Authors:  M P Cancro
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

4.  DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF.

Authors:  Amanda L Gavin; Djemel Aït-Azzouzene; Carl F Ware; David Nemazee
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

5.  Cross-strand interactions of fluorinated amino acids in β-hairpin constructs.

Authors:  Ginevra A Clark; James D Baleja; Krishna Kumar
Journal:  J Am Chem Soc       Date:  2012-10-18       Impact factor: 15.419

Review 6.  Manipulating B cell homeostasis: a key component in the advancement of targeted strategies.

Authors:  Laura S Treml; William J Quinn; John F Treml; Jean L Scholz; Michael P Cancro
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-05-30       Impact factor: 4.291

7.  TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules.

Authors:  Sharron A N Brown; Heather N Hanscom; Hong Vu; Shelesa A Brew; Jeffrey A Winkles
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

8.  Binding efficiency of protein-protein complexes.

Authors:  Eric S Day; Shaun M Cote; Adrian Whitty
Journal:  Biochemistry       Date:  2012-11-01       Impact factor: 3.162

9.  VNAR single-domain antibodies specific for BAFF inhibit B cell development by molecular mimicry.

Authors:  Julien Häsler; Martin F Flajnik; Gareth Williams; Frank S Walsh; J Lynn Rutkowski
Journal:  Mol Immunol       Date:  2016-05-20       Impact factor: 4.407

10.  Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma.

Authors:  Felix Oden; Stephen F Marino; Janko Brand; Susanne Scheu; Cathleen Kriegel; Daniel Olal; Anna Takvorian; Jörg Westermann; Buket Yilmaz; Michael Hinz; Oliver Daumke; Uta E Höpken; Gerd Müller; Martin Lipp
Journal:  Mol Oncol       Date:  2015-03-31       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.